Skip to main content
Log in

Measurement of indocyanine green plasma disappearance rate by two different dosages

  • Brief Report
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

While using a transcutaneous system for assessment of liver function by indocyanine green plasma disappearance rate (ICG-PDR) in critically ill patients, we compared the agreement between ICG-PDR obtained by the recommended standard ICG dosage (0.5 mg/kg) and a reduced dosage (0.25 mg/kg).

Design

Clinical study.

Setting

Intensive care unit of a university hospital.

Patients

Critically ill patients (n=16, 5 female, 11 male) who underwent liver function monitoring by ICG-PDR for clinical indication.

Measurements and results

We analyzed 31 pairs of ICG-PDR measurements by applying the recommended dosage (0.5 mg/kg, ICG-PDR0.5) and a reduced dosage (0.25 mg/kg, ICG-PDR0.25). For each comparative measurement either first 0.5 mg/kg or 0.25 mg/kg of ICG was injected in a random fashion and followed by the corresponding dosage 60 min later. All patients were sedated and mechanically ventilated via a tracheal tube. Each patient was monitored by an ICG finger clip which was connected to a liver function monitoring system (LiMon, Pulsion Medical Systems, Germany). ICG-PDR0.25 was 2.7–25.0 %/min and ICG-PDR0.5 4.5–24.5 %/min, respectively. Linear regression analysis revealed ICG-PDR0.25=1.13·ICG-PDR0.5−0.66 %/min (r=0.95, p<0.0001) with a mean bias 1.0 %/min (standard deviation 2.5 %/min). The 15 min residual rates were also highly correlated (r=0.92, p<0.0001) with a mean bias of 0.3%.

Conclusion

A reduced dosage of ICG (0.25 mg/kg) is sufficiently accurate for transcutaneous measurement of ICG-PDR in critically ill patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Reference

  1. Sakka SG, Reinhart K, Meier-Hellmann A (2002) Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 122:1715–1720

    Article  PubMed  Google Scholar 

  2. Kholoussy AM, Pollack D, Matsumoto T (1984) Prognostic significance of indocyanine green clearance in critically ill surgical patients. Crit Care Med 12:115–116

    CAS  PubMed  Google Scholar 

  3. Sakka SG, Reinhart K, Meier-Hellmann A (2001) Comparison of invasive and noninvasive measurements of indocyanine green plasma disappearance rate in critically ill patients with mechanical ventilation and stable hemodynamics. Intensive Care Med 26:1553–1556

    Article  Google Scholar 

  4. Krenn CG, Schäfer B, Berlakovich GA, Steininger R, Steltzer H, Spiss CK (1998) Detection of graft non-function after liver transplantation by assessment of indocyanine green kinetics. Anesth Analg 87:34–36

    CAS  PubMed  Google Scholar 

  5. Kimura S, Yoshioka T, Shibuya M, Sakano T, Tanaka R, Matsuyama S (2001) Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Crit Care Med 29:1159–1163

    CAS  PubMed  Google Scholar 

  6. Hashimoto M, Watanabe G (2000) Hepatic parenchymal cell volume and the indocyanine green tolerance test. J Surg Res 92:222–227

    Article  CAS  PubMed  Google Scholar 

  7. Lehmann C, Taymoorian K, Wauer H, Krausch D, Birnbaum J, Kox WJ (2000) Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock. Intensive Care Med 26:1557–1560

    CAS  PubMed  Google Scholar 

  8. Orii R, Sugawara Y, Hayashida M, Yamada Y, Chang K, Takayama T, Makunchi M, Manaoka K (2000) Effects of amrinone on ischaemia-reperfusion injury in cirrhotic patients undergoing hepatectomy: a comparative study with prostaglandin E1. Br J Anaesth 85:389–395

    CAS  PubMed  Google Scholar 

  9. Devlin J, Ellis AE, McPeake J, Heaton N, Wendon JA, Williams R (1997) N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. Crit Care Med 25:236–242

    Article  CAS  PubMed  Google Scholar 

  10. Sakka SG, Reinhart K, Wegscheider K, Meier-Hellmann A (2001) Variability of splanchnic blood flow in patients with sepsis. Intensive Care Med 27:1281–1287

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samir G. Sakka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakka, S.G., Koeck, H. & Meier-Hellmann, A. Measurement of indocyanine green plasma disappearance rate by two different dosages. Intensive Care Med 30, 506–509 (2004). https://doi.org/10.1007/s00134-003-2091-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-003-2091-6

Keywords

Navigation